Category: Whitepapers

Archive

Categories

Interviews with leading Life Sciences companies: Pixie Dust Technologies
by Venture Valuation
January 15, 2024
Venture Valuation/Biotechgate Announces Participation in Biotech Showcase, the J.P. Morgan 41st Annual Healthcare Conference 2024 and RESI
by Venture Valuation
December 19, 2023
Venture Valuation Strengthens its Presence in North America With Sales Team Expansion
by Venture Valuation
December 14, 2023
Interviews with leading Life Sciences companies: Rebirthel
by Venture Valuation
November 2, 2023
Life Sciences M&A Report: Half-Year 2023
by Venture Valuation
October 23, 2023

Socials Share

Whitepaper: Life Sciences – 409A valuation vs. valuation to raise money

Venture Valuation

Apr 16, 2019

The US Internal Revenue Code has numerous regulations which must be adhered to in order … Read more
Know More
Whitepaper: Collaboration of Venture Valuation and Ferring Pharmaceuticals

Venture Valuation

Mar 21, 2019

Switzerland, March 2019: Venture Valuation has been working with Ferring Pharmaceutical supporting the company with … Read more
Know More
Whitepaper: The Rise of Bigger, Earlier M&A Deals for Biotech

Venture Valuation

Aug 28, 2018

Continuing a trend that began in 2017, this year has seen the rise of big … Read more
Know More
Whitepaper: Focus on the Antibiotics Market

Venture Valuation

Jul 25, 2017

The antibiotics market is expected to reach USD 57.0 billion by 2024. Rising prevalence of … Read more
Know More